A recent study by Pandey et al. utilizing whole-exome sequencing and mRNA microarray analysis demonstrated that Palbociclib-resistant breast cancer cells exhibited upregulation of type I interferon (IFN) pathways and immune checkpoint inhibitory signals. This evidence concerns the gene IFNA1 and breast cancer.